RE:RE:New Press Release - Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMOMatt doesn't control the markets you silly goose. His job is to produce strong results, which he continues to do.
Communication has been poor but ONCY continues to show why they're going to get bought out.